Organon (LTS:0A9W) Other Long-Term Liabilities : $549 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Organon Other Long-Term Liabilities?

Organon's other long-term liabilities for the quarter that ended in Mar. 2024 was $549 Mil.

Organon's quarterly other long-term liabilities declined from Sep. 2023 ($421 Mil) to Dec. 2023 ($412 Mil) but then increased from Dec. 2023 ($412 Mil) to Mar. 2024 ($549 Mil).

Organon's annual other long-term liabilities declined from Dec. 2021 ($463 Mil) to Dec. 2022 ($411 Mil) but then increased from Dec. 2022 ($411 Mil) to Dec. 2023 ($412 Mil).

Organon Other Long-Term Liabilities Historical Data

The historical data trend for Organon's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Other Long-Term Liabilities Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Organon Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial														-	-	-	-	-

Organon Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Organon Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Organon's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon (LTS:0A9W) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (LTS:0A9W) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

OGN:USA OGN:Mexico 1OGN:Italy 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.

Organon (LTS:0A9W) Headlines

No Headlines